Endothelin-1-induced in vitro cerebral venoconstriction is mediated by endothelin ET A receptors

By Fernandez N.   Monge L.   Garcia-Villalon A.L.   Garcia J.L.   Gomez B.   Dieguez G.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 483-490

Elsevier

Access to resources Recommend Favorite

Action of metformin on erythrocyte membrane fluidity in vitro and in vivo

By Muller S.   Denet S.   Candiloros H.   Barrois R.   Wiernsperger N.   Donner M.   Drouin P.  

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 103-110

Elsevier

Access to resources Recommend Favorite

Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes

By Li Weiguo   Kelly-Cobbs Aisha I.   Mezzetti Erin M.   Fagan Susan C.   Ergul Adviye  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 8, 2010-08 ,pp. : 788-795

NRC Research Press

Access to resources Recommend Favorite

Amelioration of hypoperfusion after traumatic brain injury by in vivo endothelin-1 knockout

By Petrov Theodor  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 5, 2009-05 ,pp. : 379-386

NRC Research Press

Access to resources Recommend Favorite

Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo

By Karjalainen Marjo   Neuvonen Pertti   Backman Janne  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 511-519

Springer Publishing Company

Access to resources Recommend Favorite